Helicobacter pylori strains and histologically-related lesions affect the outcome of triple eradication therapy: a study from southern Italy

Aliment Pharmacol Ther. 2003 Feb;17(3):421-8. doi: 10.1046/j.1365-2036.2003.01443.x.

Abstract

Background: Certain evidence suggests that Helicobacter pylori strains expressing genes for cytotoxin production show a higher sensitivity than non-cytotoxic organisms to eradication treatment. No data are available on the involvement of bacterium-related lesions in different therapeutic outcomes.

Aims: (i) To investigate whether differences in eradication rates may be related to the different expression of virulent strains (cagA, vacA, iceA) in patients undergoing proton pump inhibitor-based triple therapy, and (ii) to evaluate whether therapeutic outcome may be affected by bacterium-induced gastric lesions.

Methods: One hundred and ten H. pylori-positive subjects were enrolled. H. pylori was genotyped by polymerase chain reaction. Treatment consisted of lansoprazole-amoxicillin-clarithromycin, twice daily for 1 week. Eradication was checked by urea breath test.

Results: The eradication rate was 70%, and the absence of cagA was associated with unsuccessful treatment. No difference between the groups with successful and unsuccessful eradication was found with regard to vacA and iceA. Lympho-epithelial lesions and fibrosis were associated with unsuccessful treatment.

Conclusions: The present data confirm the importance of cagA (but not vacA and iceA) as a predictor of successful eradication. When fibrosis and lympho-epithelial lesions are present, therapy appears to be less effective. Therefore, these histological features may be involved in an unsuccessful therapeutic outcome.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Bacterial*
  • Bacterial Outer Membrane Proteins / genetics
  • Bacterial Proteins / genetics
  • Carrier Proteins / genetics
  • DNA, Bacterial / analysis
  • Female
  • Gastroscopy
  • Genotype
  • Helicobacter Infections / prevention & control*
  • Helicobacter pylori / classification*
  • Helicobacter pylori / genetics
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction / methods
  • Treatment Outcome

Substances

  • Antigens, Bacterial
  • Bacterial Outer Membrane Proteins
  • Bacterial Proteins
  • Carrier Proteins
  • DNA, Bacterial
  • UreE protein, Bacteria
  • VacA protein, Helicobacter pylori
  • cagA protein, Helicobacter pylori
  • ice nucleation protein